Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.12% Nasdaq Down0.18%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS

7.42 Up 0.25(3.49%) 1:07PM EDT - Nasdaq Real Time Price

Add to Portfolio
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Jun 13
Next Qtr.
Sep 13
Current Year
Dec 13
Next Year
Dec 14
Avg. Estimate-0.14-0.14-0.57-0.39
No. of Analysts8.008.008.008.00
Low Estimate-0.19-0.24-0.75-0.67
High Estimate-0.10-0.08-0.44-0.18
Year Ago EPS-0.13-0.18-0.48-0.57
Revenue EstCurrent Qtr.
Jun 13
Next Qtr.
Sep 13
Current Year
Dec 13
Next Year
Dec 14
Avg. Estimate10.85M11.94M45.54M59.66M
No. of Analysts7788
Low Estimate7.80M7.80M35.10M34.11M
High Estimate12.57M17.50M53.80M86.10M
Year Ago Sales7.76M5.33M42.32M45.54M
Sales Growth (year/est)39.90%123.80%7.60%31.00%
Earnings HistoryJun 12Sep 12Dec 12Mar 13
EPS Est-0.15-0.14-0.15-0.15
EPS Actual-0.13-0.18-0.04-0.17
Difference0.02-0.040.11-0.02
Surprise %13.30%-28.60%73.30%-13.30%
EPS TrendsCurrent Qtr.
Jun 13
Next Qtr.
Sep 13
Current Year
Dec 13
Next Year
Dec 14
Current Estimate-0.14-0.14-0.57-0.39
7 Days Ago-0.14-0.14-0.57-0.39
30 Days Ago-0.13-0.14-0.55-0.32
60 Days Ago-0.13-0.14-0.55-0.32
90 Days Ago-0.13-0.15-0.54-0.29
EPS RevisionsCurrent Qtr.
Jun 13
Next Qtr.
Sep 13
Current Year
Dec 13
Next Year
Dec 14
Up Last 7 Days0111
Up Last 30 Days1321
Down Last 30 Days1121
Down Last 90 DaysN/AN/AN/AN/A
Growth EstHALOIndustrySectorS&P 500
Current Qtr.-7.70%N/AN/A11.80%
Next Qtr.22.20%N/AN/A16.60%
This Year-18.80%4.70%9.70%9.10%
Next Year31.60%16.00%13.20%12.60%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A13.00%13.69%9.37%
Price/Earnings (avg. for comparison categories)-14.0034.873.1113.41
PEG Ratio (avg. for comparison categories)N/A2.75-0.771.34
Currency in USD.